Litigation Details for RECKITT BENCKISER PHARMACEUTICALS, INC. v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D.N.J. 2014)
✉ Email this page to a colleague
RECKITT BENCKISER PHARMACEUTICALS, INC. v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D.N.J. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-09-22 |
| Court | District Court, D. New Jersey | Date Terminated | 2015-07-21 |
| Cause | 35:271 Patent Infringement | Assigned To | Michael Andre Shipp |
| Jury Demand | Plaintiff | Referred To | Tonianne J. Bongiovanni |
| Patents | 8,765,167 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in RECKITT BENCKISER PHARMACEUTICALS, INC. v. BIODELIVERY SCIENCES INTERNATIONAL, INC.
The small molecule drugs covered by the patent cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for RECKITT BENCKISER PHARMACEUTICALS, INC. v. BIODELIVERY SCIENCES INTERNATIONAL, INC. (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-09-22 | 1 | action for patent infringement related to United States Patent No. 8,765,167 (“the ’167 patent”), arising… (Infringement as to U.S. Patent No. 8,765,167) 22. Plaintiffs reallege the…THE ASSERTED PATENT 15. Plaintiff MonoSol is the lawful owner of the ’167 patent. The ’167 …’167 patent; D. A judgment finding that Defendants’ infringement of the ’167 patent has …arising under the Patent Laws of the United States, Title 35 of the United States Code. 2. | External link to document | |
| 2014-12-11 | 14 | Defendants' Memorandum of Law In Support of Their Motion to Dismiss | infringed U.S. Patent No. 8,765,167 (the “’167 patent”), a patent closely related to the patents-in-suit in…a declaratory judgment that U.S. Patent No. 8,475,832 – the patent asserted by Plaintiffs in the First…knew of the patent-in-suit, specifically intended that a third party infringe the patent-in-suit, and…aware of the recently-issued ’167 patent, or understood the patent sufficiently to have knowledge that…of the ’167 patent, nor that it had knowledge third parties were infringing that patent. | External link to document |
| 2015-07-21 | 27 | infringement of a patent related to Suboxone, U.S. Patent No. 8,765,167 (the “’167 patent”). (Pls.’ Opp’n…making it. (Ia'. il 15; Ex. A-l, U.S. Patent No. 8,765,167, Abstract (filed Sep. 8, 2006), ECF No. …’832 Patent or U.S. Patent No. 7,897,080 (the “’08() Patent”).4 (Ia'. il 7.) The ’080 Patent is owned…alleged that Bunavail infringed U.S. Patent No. 8,4752832 (the “’832 Patent”). (Ic!. iiil 42-5 l .) RBP and…exclusive licensees of the Patent. (Chiistie Decl., Ex. 5 il 9.) The ’832 Patent is entitled “Sublingual | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
